Amgen (AMGN) Stock: Buy, Sell, or Hold?
$465.67
-1.39 (-0.30%)
▼
5d:
+1.14%
30d:
+7.29%
90d:
+11.04%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 03, 2026
0d
Protect AMGN Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
39/100
Position
EXTENDED
30-Day Fair Range
$420.37 – $465.04
Position: EXTENDED
Forward P/E & Valuation
18.6x
STRETCHED
vs 15.9x historical avg
Wall Street Target
$431.81
-7.3% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$447.04 / $483.99
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: AMGN shows conflicting indicators. Wait for confirmation before entering.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Oct 26, 2026 at $440.64 · last confirmed Nov 10, 2026
Strength: 5.3/10
Get Alerted When AMGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$512.97
Based on 5.2% avg growth
INTRINSIC VALUE TODAY
$318.51
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AMGN is currently trading at $465.67, which is considered extended relative to its 30-day fair value range of $420.37 to $465.04. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.6) compared to its historical average (15.9). At these levels, the market is pricing in 5.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AMGN is in a strong uptrend. Immediate support is located at $447.04, while resistance sits at $483.99.
Market Sentiment: AMGN scores 24/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AMGN is in a strong uptrend. Immediate support is located at $447.04, while resistance sits at $483.99.
Market Sentiment: AMGN scores 24/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$420.37 -
$465.04
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
20.5%
Trading Range & Key Levels
30-Day Trading Range
$420.37 -
$465.04
Current vs Trading Range
EXTENDED
Support Level
$447.04
Resistance Level
$483.99
Current Trend
Strong Uptrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding AMGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (24/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($431.81)
- NEUTRAL: Trading at premium valuation - market expects 5.4% growth which is achievable
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
18.59
Wall Street Target
$431.81
(-7.3%)
Revenue Growth (YoY)
8.5%
Earnings Growth (YoY)
19.4%
Profit Margin
24.1%
Valuation Premium vs History
+5.4% premium
PE vs Historical
18.6 vs 15.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.4%
(market-implied from PE analysis)
1-Year Target
$490.82
(+5%)
2-Year Target
$517.32
(+11%)
3-Year Target
$545.26
(+17%)
3-Yr Target (if PE normalizes)
(PE: 19→16)
PE COMPRESSION
$466.23
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 6.4%)
$599.29
(+29%)
Base:
(SPY PE: 18.6, Growth: 6.4%)
$561.11
(+21%)
Bear:
(PE: 15.8, Growth: 6.4%)
$476.95
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 27.08 | Current EPS (TTM): $17.25
Bull Case
$745.86
(+60%)
Analyst growth 45.2%, PE expands to 29.8
Base Case
$678.06
(+46%)
Market implied 45.2%, PE stable at 27.1
Bear Case
$317.60
(-32%)
Severe decline -20.0%, PE contracts to 23.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share AMGN Analysis
Share this live AMGN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AMGN)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on StockTwits regarding $AMGN's price stability and pipeline excitement. A new Amgen drug could potentially reduce obesity patient injections from 52 to 4 a year.
Key Retail Themes:
StockTwits bullish sentiment
New Amgen drug reducing obesity injections
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 5:46 AM ET
Data refreshes hourly during market hours. Next update: 6:46 AM
Data refreshes hourly during market hours. Next update: 6:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1453 | 39 SELL |
|
ABBV
AbbVie Inc |
STRONG BUY
29 analysts |
$306 | 49 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
28 analysts |
$175 | 47 HOLD |
|
MRK
Merck & Company Inc |
BUY
28 analysts |
$162 | 53 HOLD |
|
BIIB
Biogen Inc |
BUY
36 analysts |
$266 | 41 HOLD |
Advanced AMGN Option Strategies
Professional options setups generated by AI based on today's AMGN price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AMGN Research Pages
